Clairo

Director, Product Marketing, Digital Physiology

United States

Apply now

$120,000 – $180,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Digital Health, MarketingIndustries

Requirements

Candidates should possess a Bachelor's degree in Marketing, Business, or a related field, and have at least 8 years of experience in product marketing, preferably within the healthcare or digital health space. Strong understanding of market research, competitive analysis, and marketing strategy development is essential, along with experience in demand generation and sales enablement.

Responsibilities

The Director, Product Marketing, Digital Physiology will lead the development and execution of product and marketing strategy, capturing market insights and translating them into actionable positioning. They will partner with the Product Line Executive and leadership team to drive messaging and positioning, conceive and support new marketing programs, and enable sales teams with world-class tools and messaging. Additionally, they will oversee market intelligence, brand strategy, marketing strategy, demand generation, lead generation and nurturing, sales enablement, and content development, while also serving as a team player and demonstrating self-sufficiency and agility.

Skills

Market Research

Competitive Analysis

Marketing Strategy

Demand Generation

Sales Enablement

Messaging

Brand Strategy

Content Development

Lead Generation

Digital Marketing

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free